Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbhfiledCriticalMerck Patent Gmbh
Priority to ARP010105429priorityCriticalpatent/AR034701A1/en
Publication of AR034701A1publicationCriticalpatent/AR034701A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se relaciona con el campo de la química terapéutica y más particularmente con la preparación de nuevos productos medicinales para el tratamiento de la diabetes. Específicamente, un objeto de la invención consiste en nuevos productos medicinales antidiabéticos que comprenden una combinación de dos principios activos que son eficaces por vía oral, en dosis subliminales, formada por una biguanida antidiabética y una sulfonamida antidiabética, en combinación o en forma de mezcla con uno o más excipientes inertes, aceptables para uso farmacéutico. La invención también se relaciona con un proceso para la preparación de dichos productos medicinales formados a partir de una biguanida y una sulfonamida.It is related to the field of therapeutic chemistry and more particularly with the preparation of new medicinal products for the treatment of diabetes. Specifically, an object of the invention consists of new antidiabetic medicinal products comprising a combination of two active ingredients that are effective orally, in subliminal doses, formed by an antidiabetic biguanide and an antidiabetic sulfonamide, in combination or in the form of a mixture with one or more inert excipients, acceptable for pharmaceutical use. The invention also relates to a process for the preparation of said medicinal products formed from a biguanide and a sulfonamide.
ARP0101054292001-11-212001-11-21
NEW PHARMACEUTICAL COMPOSITIONS WITH ANTI-DIABETIC ACTION AND PROCESS FOR PREPARATION
AR034701A1
(en)
LACTAMA COMPOUND (N) - ((S) -2-HIDROXI-3-METHYLBUTIRILE) -1- (L-ALANINIL) - (S) -1-AMINO-3-METHYL-4,5,6,7-TETRAHYDRO -2H-3-BENZAZEPIN-2-ONA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE FOR THE INHIBITION OF THE B-AMYLOID PEPTIDE RELEASE AND / OR ITS SYNTHESIS THAT USES IT AND ITS USE FOR THE FABR
SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES
COMPOSITION OF VALDECOXIB INTRAORAL DISINTEGRATION, PROCESS FOR PREPARATION, TABLET OBTAINED AND THE USE OF SUCH COMPOSITION IN THE PREPARATION OF A MEDICINAL PRODUCT.
DERIVED FROM THE 3-ARIL-2-HYDROXIPROPIONIC ACID, PROCESS AND INTERMEDIARY FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS, USE OF SUCH COMPOUND IN THE PREPARATION OF A MEDICINAL PRODUCT, METHOD FOR THE PROPHYLAXIS AND / OR TREATMENT OF CLINIC ASSOCIATED RESISTANCES AND FORMULATION
DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA
ORAL DOSING UNIT INCLUDING AN ANTAGONIST AGENT FOR PUMPS OF PROTONS AND EXCIPIENTS OF BASIC CHARACTER; PROCEDURE FOR PREPARATION, USEFUL TO TREAT DISEASES CAUSED BY AN INCREASED SECRETION OF GASTRIC ACIDS.
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION
A 6-AZAURACILO COMPOUND THAT INHIBITES IL-5, A COMPOSITION THAT UNDERSTANDS IT, A PROCESS TO PREPARE SUCH COMPOSITION, AND THE USE OF THIS COMPOUND TO MANUFACTURE OF A MEDICINAL PRODUCT AND OF A DIAGNOSTIC AGENT